- Home
- AFMD vs SRZN Comparison
AFMD vs SRZN Comparison
Compare AFMD & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AFMD
- SRZN
- Stock Information
- Founded
- AFMD 2000
- SRZN 2015
- Country
- AFMD Germany
- SRZN United States
- Employees
- AFMD N/A
- SRZN N/A
- Industry
- AFMD Biotechnology: Pharmaceutical Preparations
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- AFMD Health Care
- SRZN Health Care
- Exchange
- AFMD Nasdaq
- SRZN Nasdaq
- Market Cap
- AFMD 45.6M
- SRZN 38.1M
- IPO Year
- AFMD 2014
- SRZN N/A
- Fundamental
- Price
- AFMD $1.27
- SRZN $9.94
- Analyst Decision
- AFMD Strong Buy
- SRZN
- Analyst Count
- AFMD 5
- SRZN 0
- Target Price
- AFMD $13.50
- SRZN N/A
- AVG Volume (30 Days)
- AFMD 502.9K
- SRZN 55.8K
- Earning Date
- AFMD 11-14-2024
- SRZN 11-06-2024
- Dividend Yield
- AFMD N/A
- SRZN N/A
- EPS Growth
- AFMD N/A
- SRZN N/A
- EPS
- AFMD N/A
- SRZN N/A
- Revenue
- AFMD $6,287,085.00
- SRZN $10,000,000.00
- Revenue This Year
- AFMD N/A
- SRZN N/A
- Revenue Next Year
- AFMD $28.44
- SRZN N/A
- P/E Ratio
- AFMD N/A
- SRZN N/A
- Revenue Growth
- AFMD N/A
- SRZN N/A
- 52 Week Low
- AFMD $1.19
- SRZN $6.00
- 52 Week High
- AFMD $8.95
- SRZN $16.19
- Technical
- Relative Strength Index (RSI)
- AFMD 16.00
- SRZN 51.34
- Support Level
- AFMD $1.40
- SRZN $9.52
- Resistance Level
- AFMD $2.21
- SRZN $11.06
- Average True Range (ATR)
- AFMD 0.24
- SRZN 1.17
- MACD
- AFMD -0.08
- SRZN -0.03
- Stochastic Oscillator
- AFMD 3.33
- SRZN 27.72
About AFMD Affimed N.V.
Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).